Price Movement and Market Context
On 5 May 2026, Fortis Healthcare Ltd’s share price closed at ₹952.75, up from the previous close of ₹923.35. The intraday range saw a low of ₹926.10 and a high of ₹961.05, indicating a positive price momentum. The stock remains comfortably above its 52-week low of ₹623.45 but still below its 52-week high of ₹1,105.00, suggesting room for both upside and downside volatility.
Comparatively, Fortis has outperformed the Sensex significantly over multiple time horizons. The stock’s one-month return stands at 20.78%, vastly exceeding the Sensex’s 5.39%. Year-to-date, Fortis has gained 7.83% while the Sensex has declined by 9.33%. Over the past year, the stock surged 40.53% against the Sensex’s negative 4.02%. Longer-term returns are even more impressive, with a three-year gain of 260.62% versus 25.13% for the Sensex, and a five-year return of 342.52% compared to 60.13% for the benchmark. Over a decade, Fortis has delivered a staggering 449.61% return, more than double the Sensex’s 207.83%.
Technical Indicator Analysis
The technical trend for Fortis Healthcare has transitioned from mildly bearish to sideways, reflecting a consolidation phase after recent gains. This shift is supported by a mixed bag of indicator signals across different timeframes.
MACD (Moving Average Convergence Divergence): The weekly MACD is bullish, signalling positive momentum in the near term. However, the monthly MACD remains mildly bearish, indicating that longer-term momentum has yet to fully confirm a sustained uptrend. This divergence suggests that while short-term traders may find opportunities, longer-term investors should remain cautious.
RSI (Relative Strength Index): Both weekly and monthly RSI readings currently show no clear signal, hovering in neutral zones. This lack of overbought or oversold conditions implies that the stock is neither stretched nor deeply discounted technically, reinforcing the sideways trend narrative.
Bollinger Bands: Both weekly and monthly Bollinger Bands are bullish, indicating that price volatility is expanding upwards and the stock is trending towards the upper band. This is a positive sign for momentum traders looking for continuation of the recent price strength.
Moving Averages: Daily moving averages remain mildly bearish, suggesting that short-term price action has not decisively broken above key average levels. This could act as a resistance zone, requiring a sustained breakout for a stronger bullish confirmation.
KST (Know Sure Thing): The weekly KST is mildly bullish, supporting the short-term positive momentum, while the monthly KST remains mildly bearish, echoing the MACD’s longer-term caution.
Dow Theory, OBV (On-Balance Volume): Both weekly and monthly Dow Theory and OBV indicators show no clear trend, indicating a lack of strong directional conviction from volume and price action perspectives.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- - Current monthly selection
- - Single best opportunity
- - Elite universe pick
Mojo Score and Grade Update
Fortis Healthcare currently holds a Mojo Score of 40.0, categorised as a Sell rating, a downgrade from its previous Hold grade as of 6 March 2026. This downgrade reflects a cautious stance based on the company’s technical and fundamental outlook. The mid-cap stock’s market capitalisation and sector positioning in hospitals add complexity to its risk profile, especially amid mixed technical signals.
Investors should note that the downgrade aligns with the mildly bearish daily moving averages and the longer-term bearish MACD and KST readings, suggesting that while short-term momentum is positive, the overall trend remains uncertain.
Comparative Performance and Sector Context
Fortis Healthcare’s robust outperformance relative to the Sensex over one month, year-to-date, and longer periods highlights its resilience and growth potential within the hospital sector. However, the sideways technical trend and mixed indicator signals suggest that the stock may be entering a consolidation phase, potentially reflecting sector-specific challenges or broader market caution.
Given the hospital sector’s sensitivity to regulatory changes, healthcare demand fluctuations, and operational risks, investors should weigh Fortis’s technical momentum against these fundamental factors.
Considering Fortis Healthcare Ltd? Wait! SwitchER has found potentially better options in Hospital and beyond. Compare this mid-cap with top-rated alternatives now!
- - Better options discovered
- - Hospital + beyond scope
- - Top-rated alternatives ready
Investor Takeaways and Outlook
Fortis Healthcare’s recent price momentum and technical indicator signals present a mixed picture. The bullish weekly MACD and Bollinger Bands suggest potential for further upward movement in the short term, supported by a 3.18% day gain and strong relative returns versus the Sensex. However, the mildly bearish monthly MACD and KST, alongside daily moving averages remaining mildly bearish, counsel caution.
Investors should monitor key technical levels closely. A sustained break above the daily moving averages and the 52-week high of ₹1,105.00 could confirm a stronger bullish trend. Conversely, failure to hold above current support levels near ₹926 could signal renewed downside risk.
Given the sideways trend and neutral RSI readings, the stock may consolidate in the near term, offering potential trading opportunities for momentum-focused investors but requiring patience from longer-term holders.
Overall, Fortis Healthcare remains a stock with strong historical returns and sector relevance but currently faces a technical crossroads. The downgrade to a Sell Mojo Grade underscores the need for careful risk management and consideration of alternative investment options within the hospital sector and broader healthcare space.
Summary of Key Technical Metrics:
- Current Price: ₹952.75 (up 3.18% on 5 May 2026)
- 52-Week Range: ₹623.45 - ₹1,105.00
- Weekly MACD: Bullish
- Monthly MACD: Mildly Bearish
- Weekly & Monthly Bollinger Bands: Bullish
- Daily Moving Averages: Mildly Bearish
- Weekly KST: Mildly Bullish; Monthly KST: Mildly Bearish
- RSI (Weekly & Monthly): No Signal
- Dow Theory & OBV: No Trend
- Mojo Score: 40.0 (Sell), downgraded from Hold on 6 Mar 2026
Investors should continue to track Fortis Healthcare’s technical developments alongside fundamental news flow to gauge the stock’s trajectory in a dynamic market environment.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
